Daly Thomas M, Hill Harry R
Robert J. Tomsich Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA
ARUP Laboratories, Salt Lake City, Utah, USA Departments of Pathology, Pediatrics, and Medicine, University of Utah, Salt Lake City, Utah, USA.
Clin Vaccine Immunol. 2015 Feb;22(2):148-52. doi: 10.1128/CVI.00735-14. Epub 2014 Dec 17.
Pneumococcal vaccination is a commonly used technique for assessing the humoral immune status of a patient suspected of having immunodeficiency. Interpretation of what constitutes an adequate response, however, can be challenging. This is due to the complexity of the data generated from serotype-specific assays, historical variations in the assays used to measure pneumococcal antibodies, and varying recommendations on the relevant cut points that define response. In this review, we summarize the historical evolution of assays used for this purpose and discuss the analytical considerations that have influenced published data. We also examine current clinical recommendations for defining an adequate response to vaccination, with a particular focus on the interpretation of serotype-specific data generated by multiplex assays.
肺炎球菌疫苗接种是一种常用技术,用于评估疑似免疫缺陷患者的体液免疫状态。然而,对什么构成充分反应的解读可能具有挑战性。这是由于血清型特异性检测产生的数据复杂、用于测量肺炎球菌抗体的检测方法存在历史差异,以及关于定义反应的相关切点的不同建议。在本综述中,我们总结了用于此目的的检测方法的历史演变,并讨论了影响已发表数据的分析因素。我们还研究了当前关于定义疫苗接种充分反应的临床建议,特别关注多重检测产生的血清型特异性数据的解读。